Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02652 CF PHARMTECH
RT Nominaldown22.320 -0.780 (-3.377%)
Disclosure of Interest
More
08/10/2025 16:08
{New Stock}CF PHARMTECH(02652) ends up 161.02% at HK$38.5
[ET Net News Agency, 8 October 2025] Shares of CF PHARMTECH (02652) closed at HK$38.5 in its first trading day, or 1.61 times higher than its offe ... View All View All

08/10/2025 09:20    {New Stock}CF PHARMTECH(02652) opens up 218.64% at HK$47

06/10/2025 18:35    {New Stock}CF PHARMTECH ends up 217.97% on grey market

06/10/2025 16:20    {New Stock}CF PHARMTECH up 137.29% at HK$35 on grey market

Remark: Real time quote last updated: 26/03/2026 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.